Centaurus Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$322K Sell
6,689
-326
-5% -$15.2K 0.02% 656
2025
Q4
$340K Sell
7,015
-1,019
-13% -$50.5K 0.02% 643
2025
Q3
$379K Buy
8,034
+2,667
+50% +$129K 0.02% 609
2025
Q2
$259K Buy
5,367
+294
+6% +$15K 0.02% 651
2025
Q1
$281K Buy
5,073
+1,037
+26% +$56.1K 0.02% 592
2024
Q4
$195K Sell
4,036
-154
-4% -$7.83K 0.01% 667
2024
Q3
$241K Sell
4,190
-114
-3% -$6.16K 0.02% 596
2024
Q2
$209K Buy
4,304
+2,193
+104% +$106K 0.01% 597
2024
Q1
$103K Buy
+2,111
New +$103K 0.01% 757
2018
Q3
Sell
-694
Closed -$28K 1815
2018
Q2
$28K Buy
+694
New +$27.3K ﹤0.01% 1142

Other funds holding SNY

Centaurus Financial's SNY Position: Q1 2026 in Review

Centaurus Financial reduced its Sanofi (SNY) stake by 4.6% in Q1 2026, selling an estimated $15.2K and leaving 6,689 shares worth $322K. The position accounts for 0.02% of the portfolio, ranked #656.

Centaurus Financial first reported a position in SNY in Q2 2018 and has held it in 10 quarters since. The position peaked at $379K in Q3 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Centaurus Financial held 6,689 shares of Sanofi worth $322K as of Q1 2026.
  • Centaurus Financial sold 326 Sanofi shares in Q1 2026, an estimated $15.2K.
  • Sanofi made up 0.02% of Centaurus Financial's portfolio in Q1 2026, its #656 holding.
  • Centaurus Financial first reported a position in Sanofi in Q2 2018 and has held it in 10 quarters since.
  • Centaurus Financial's Sanofi position peaked at $379K in Q3 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.